series-a
Stage
1
Investors
About
Circular Genomics develops blood-based biomarker tests using brain-derived circular RNA and bioinformatics to support research and clinical applications in neurological and psychiatric disorders, with an initial focus on Alzheimer’s disease.
Explore Circular Genomics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.